nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ALB—liver cancer	0.141	1	CbGaD
Mycophenolate mofetil—UGT2B7—Epirubicin—liver cancer	0.0946	0.203	CbGbCtD
Mycophenolate mofetil—UGT1A9—Sorafenib—liver cancer	0.0876	0.188	CbGbCtD
Mycophenolate mofetil—UGT1A1—Sorafenib—liver cancer	0.0716	0.154	CbGbCtD
Mycophenolate mofetil—ABCC2—Sorafenib—liver cancer	0.0436	0.0934	CbGbCtD
Mycophenolate mofetil—ABCG2—Sorafenib—liver cancer	0.0394	0.0845	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—liver cancer	0.0264	0.0567	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—liver cancer	0.0239	0.0512	CbGbCtD
Mycophenolate mofetil—ABCC2—bile canaliculus—liver cancer	0.0232	0.396	CbGeAlD
Mycophenolate mofetil—CYP3A5—Sorafenib—liver cancer	0.0218	0.0468	CbGbCtD
Mycophenolate mofetil—CYP2C8—Sorafenib—liver cancer	0.021	0.045	CbGbCtD
Mycophenolate mofetil—ABCB1—Sorafenib—liver cancer	0.0142	0.0305	CbGbCtD
Mycophenolate mofetil—ABCB1—Doxorubicin—liver cancer	0.00862	0.0185	CbGbCtD
Mycophenolate mofetil—CYP3A4—Sorafenib—liver cancer	0.00851	0.0182	CbGbCtD
Mycophenolate mofetil—ABCC2—bile duct—liver cancer	0.00726	0.124	CbGeAlD
Mycophenolate mofetil—ABCC2—bile—liver cancer	0.00558	0.0952	CbGeAlD
Mycophenolate mofetil—CYP3A4—Doxorubicin—liver cancer	0.00516	0.0111	CbGbCtD
Mycophenolate mofetil—UGT1A7—liver—liver cancer	0.0025	0.0427	CbGeAlD
Mycophenolate mofetil—CES1—gall bladder—liver cancer	0.00238	0.0406	CbGeAlD
Mycophenolate mofetil—UGT1A10—liver—liver cancer	0.00209	0.0357	CbGeAlD
Mycophenolate mofetil—UGT1A6—liver—liver cancer	0.00194	0.0332	CbGeAlD
Mycophenolate mofetil—UGT1A8—liver—liver cancer	0.00165	0.0282	CbGeAlD
Mycophenolate mofetil—ALB—gall bladder—liver cancer	0.00165	0.0282	CbGeAlD
Mycophenolate mofetil—UGT1A9—liver—liver cancer	0.00105	0.0179	CbGeAlD
Mycophenolate mofetil—SLCO1B3—liver—liver cancer	0.00104	0.0177	CbGeAlD
Mycophenolate mofetil—IMPDH2—liver—liver cancer	0.000931	0.0159	CbGeAlD
Mycophenolate mofetil—IMPDH1—liver—liver cancer	0.000925	0.0158	CbGeAlD
Mycophenolate mofetil—UGT2B7—liver—liver cancer	0.000846	0.0144	CbGeAlD
Mycophenolate mofetil—CES2—liver—liver cancer	0.000846	0.0144	CbGeAlD
Mycophenolate mofetil—UGT1A1—liver—liver cancer	0.00072	0.0123	CbGeAlD
Mycophenolate mofetil—CES1—liver—liver cancer	0.000697	0.0119	CbGeAlD
Mycophenolate mofetil—SLCO1B1—liver—liver cancer	0.000599	0.0102	CbGeAlD
Mycophenolate mofetil—ALB—liver—liver cancer	0.000484	0.00827	CbGeAlD
Mycophenolate mofetil—ABCC2—liver—liver cancer	0.000454	0.00775	CbGeAlD
Mycophenolate mofetil—ABCB1—embryo—liver cancer	0.000353	0.00602	CbGeAlD
Mycophenolate mofetil—CYP2C8—liver—liver cancer	0.00034	0.00581	CbGeAlD
Mycophenolate mofetil—ABCG2—liver—liver cancer	0.000331	0.00565	CbGeAlD
Mycophenolate mofetil—CYP3A5—liver—liver cancer	0.000307	0.00524	CbGeAlD
Mycophenolate mofetil—CYP3A4—liver—liver cancer	0.000231	0.00394	CbGeAlD
Mycophenolate mofetil—ABCB1—liver—liver cancer	0.000163	0.00279	CbGeAlD
Mycophenolate mofetil—Hypokalaemia—Epirubicin—liver cancer	0.000138	0.00081	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Sorafenib—liver cancer	0.000138	0.00081	CcSEcCtD
Mycophenolate mofetil—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000137	0.000801	CcSEcCtD
Mycophenolate mofetil—Face oedema—Doxorubicin—liver cancer	0.000136	0.000795	CcSEcCtD
Mycophenolate mofetil—Gastritis—Epirubicin—liver cancer	0.000134	0.000787	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Epirubicin—liver cancer	0.000134	0.000785	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000134	0.000785	CcSEcCtD
Mycophenolate mofetil—Cardiac arrest—Doxorubicin—liver cancer	0.000133	0.000783	CcSEcCtD
Mycophenolate mofetil—Dizziness—Sorafenib—liver cancer	0.000133	0.000782	CcSEcCtD
Mycophenolate mofetil—Mood swings—Doxorubicin—liver cancer	0.000133	0.00078	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Epirubicin—liver cancer	0.000132	0.000774	CcSEcCtD
Mycophenolate mofetil—Blood creatinine increased—Doxorubicin—liver cancer	0.000131	0.000771	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Epirubicin—liver cancer	0.000131	0.000769	CcSEcCtD
Mycophenolate mofetil—Asthma—Epirubicin—liver cancer	0.000131	0.000769	CcSEcCtD
Mycophenolate mofetil—Influenza—Epirubicin—liver cancer	0.000131	0.000769	CcSEcCtD
Mycophenolate mofetil—Dehydration—Doxorubicin—liver cancer	0.000131	0.000766	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Doxorubicin—liver cancer	0.00013	0.00076	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Epirubicin—liver cancer	0.000129	0.000754	CcSEcCtD
Mycophenolate mofetil—Vomiting—Sorafenib—liver cancer	0.000128	0.000752	CcSEcCtD
Mycophenolate mofetil—Orthostatic hypotension—Doxorubicin—liver cancer	0.000128	0.000752	CcSEcCtD
Mycophenolate mofetil—Hypokalaemia—Doxorubicin—liver cancer	0.000128	0.000749	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Epirubicin—liver cancer	0.000128	0.000749	CcSEcCtD
Mycophenolate mofetil—Rash—Sorafenib—liver cancer	0.000127	0.000746	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Sorafenib—liver cancer	0.000127	0.000745	CcSEcCtD
Mycophenolate mofetil—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000126	0.000741	CcSEcCtD
Mycophenolate mofetil—Headache—Sorafenib—liver cancer	0.000126	0.000741	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Epirubicin—liver cancer	0.000126	0.000739	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Epirubicin—liver cancer	0.000125	0.00073	CcSEcCtD
Mycophenolate mofetil—Gastritis—Doxorubicin—liver cancer	0.000124	0.000729	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000124	0.000726	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Doxorubicin—liver cancer	0.000124	0.000726	CcSEcCtD
Mycophenolate mofetil—Dysuria—Epirubicin—liver cancer	0.000123	0.000719	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Epirubicin—liver cancer	0.000123	0.000719	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Doxorubicin—liver cancer	0.000122	0.000716	CcSEcCtD
Mycophenolate mofetil—Asthma—Doxorubicin—liver cancer	0.000121	0.000711	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Doxorubicin—liver cancer	0.000121	0.000711	CcSEcCtD
Mycophenolate mofetil—Influenza—Doxorubicin—liver cancer	0.000121	0.000711	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Epirubicin—liver cancer	0.000121	0.00071	CcSEcCtD
Mycophenolate mofetil—Nausea—Sorafenib—liver cancer	0.00012	0.000703	CcSEcCtD
Mycophenolate mofetil—Weight increased—Epirubicin—liver cancer	0.000119	0.0007	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Doxorubicin—liver cancer	0.000119	0.000698	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Epirubicin—liver cancer	0.000119	0.000696	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Epirubicin—liver cancer	0.000118	0.000694	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Doxorubicin—liver cancer	0.000118	0.000693	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Epirubicin—liver cancer	0.000118	0.00069	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Epirubicin—liver cancer	0.000117	0.000686	CcSEcCtD
Mycophenolate mofetil—Infestation—Epirubicin—liver cancer	0.000117	0.000686	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Doxorubicin—liver cancer	0.000117	0.000684	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Doxorubicin—liver cancer	0.000115	0.000676	CcSEcCtD
Mycophenolate mofetil—Renal failure—Epirubicin—liver cancer	0.000115	0.000674	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Epirubicin—liver cancer	0.000115	0.000672	CcSEcCtD
Mycophenolate mofetil—Jaundice—Epirubicin—liver cancer	0.000114	0.000668	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Epirubicin—liver cancer	0.000114	0.000668	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Epirubicin—liver cancer	0.000114	0.000666	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Epirubicin—liver cancer	0.000114	0.000666	CcSEcCtD
Mycophenolate mofetil—Dysuria—Doxorubicin—liver cancer	0.000113	0.000665	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Doxorubicin—liver cancer	0.000113	0.000665	CcSEcCtD
Mycophenolate mofetil—Sweating—Epirubicin—liver cancer	0.000112	0.000657	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Doxorubicin—liver cancer	0.000112	0.000657	CcSEcCtD
Mycophenolate mofetil—Haematuria—Epirubicin—liver cancer	0.000111	0.000654	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Epirubicin—liver cancer	0.000111	0.000648	CcSEcCtD
Mycophenolate mofetil—Weight increased—Doxorubicin—liver cancer	0.00011	0.000647	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Epirubicin—liver cancer	0.00011	0.000647	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Doxorubicin—liver cancer	0.00011	0.000644	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Epirubicin—liver cancer	0.00011	0.000643	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Doxorubicin—liver cancer	0.000109	0.000642	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Epirubicin—liver cancer	0.000109	0.00064	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Doxorubicin—liver cancer	0.000109	0.000638	CcSEcCtD
Mycophenolate mofetil—Infestation—Doxorubicin—liver cancer	0.000108	0.000634	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Doxorubicin—liver cancer	0.000108	0.000634	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Epirubicin—liver cancer	0.000107	0.000627	CcSEcCtD
Mycophenolate mofetil—Renal failure—Doxorubicin—liver cancer	0.000106	0.000624	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Doxorubicin—liver cancer	0.000106	0.000622	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Epirubicin—liver cancer	0.000105	0.000619	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Doxorubicin—liver cancer	0.000105	0.000618	CcSEcCtD
Mycophenolate mofetil—Jaundice—Doxorubicin—liver cancer	0.000105	0.000618	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Epirubicin—liver cancer	0.000105	0.000617	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Doxorubicin—liver cancer	0.000105	0.000617	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Doxorubicin—liver cancer	0.000105	0.000617	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Epirubicin—liver cancer	0.000105	0.000615	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Epirubicin—liver cancer	0.000105	0.000615	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Epirubicin—liver cancer	0.000104	0.000612	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Epirubicin—liver cancer	0.000104	0.000611	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—liver cancer	0.000104	0.000608	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Epirubicin—liver cancer	0.000104	0.000608	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Epirubicin—liver cancer	0.000103	0.000606	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—liver cancer	0.000103	0.000605	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Epirubicin—liver cancer	0.000103	0.000605	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Epirubicin—liver cancer	0.000103	0.000603	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—liver cancer	0.000102	0.0006	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—liver cancer	0.000102	0.000598	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—liver cancer	0.000101	0.000595	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Epirubicin—liver cancer	0.000101	0.000593	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—liver cancer	0.000101	0.000592	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—liver cancer	9.89e-05	0.00058	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Epirubicin—liver cancer	9.81e-05	0.000575	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—liver cancer	9.78e-05	0.000574	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—liver cancer	9.76e-05	0.000572	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—liver cancer	9.74e-05	0.000571	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—liver cancer	9.74e-05	0.000571	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—liver cancer	9.71e-05	0.000569	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—liver cancer	9.71e-05	0.000569	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—liver cancer	9.66e-05	0.000567	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—liver cancer	9.64e-05	0.000565	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—liver cancer	9.59e-05	0.000562	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—liver cancer	9.57e-05	0.000561	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—liver cancer	9.54e-05	0.00056	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Epirubicin—liver cancer	9.52e-05	0.000558	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—liver cancer	9.52e-05	0.000558	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—liver cancer	9.46e-05	0.000555	CcSEcCtD
Mycophenolate mofetil—Chills—Epirubicin—liver cancer	9.42e-05	0.000552	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Epirubicin—liver cancer	9.38e-05	0.00055	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Doxorubicin—liver cancer	9.36e-05	0.000549	CcSEcCtD
Mycophenolate mofetil—Alopecia—Epirubicin—liver cancer	9.27e-05	0.000544	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—liver cancer	9.19e-05	0.000539	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—liver cancer	9.14e-05	0.000536	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—liver cancer	9.07e-05	0.000532	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—liver cancer	9.05e-05	0.000531	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—liver cancer	9.01e-05	0.000529	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—liver cancer	9e-05	0.000528	CcSEcCtD
Mycophenolate mofetil—Tension—Epirubicin—liver cancer	8.96e-05	0.000526	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—liver cancer	8.95e-05	0.000525	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—liver cancer	8.87e-05	0.00052	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—liver cancer	8.84e-05	0.000518	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—liver cancer	8.81e-05	0.000517	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—liver cancer	8.78e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—liver cancer	8.75e-05	0.000513	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—liver cancer	8.71e-05	0.000511	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—liver cancer	8.67e-05	0.000509	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—liver cancer	8.58e-05	0.000503	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—liver cancer	8.51e-05	0.000499	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—liver cancer	8.48e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—liver cancer	8.45e-05	0.000496	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—liver cancer	8.44e-05	0.000495	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—liver cancer	8.4e-05	0.000492	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—liver cancer	8.33e-05	0.000488	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—liver cancer	8.3e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—liver cancer	8.28e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—liver cancer	8.24e-05	0.000483	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—liver cancer	8.21e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—liver cancer	8.21e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—liver cancer	8.19e-05	0.00048	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—liver cancer	8.18e-05	0.00048	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—liver cancer	8.18e-05	0.00048	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—liver cancer	8.13e-05	0.000477	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—liver cancer	8.07e-05	0.000473	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—liver cancer	8.03e-05	0.000471	CcSEcCtD
Mycophenolate mofetil—Cough—Epirubicin—liver cancer	7.97e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Convulsion—Epirubicin—liver cancer	7.92e-05	0.000464	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—liver cancer	7.89e-05	0.000463	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—liver cancer	7.84e-05	0.00046	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—liver cancer	7.81e-05	0.000458	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—liver cancer	7.78e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—liver cancer	7.78e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—liver cancer	7.78e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—liver cancer	7.77e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—liver cancer	7.75e-05	0.000455	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	7.72e-05	0.000453	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—liver cancer	7.68e-05	0.000451	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—liver cancer	7.62e-05	0.000447	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—liver cancer	7.61e-05	0.000446	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—liver cancer	7.59e-05	0.000445	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—liver cancer	7.58e-05	0.000445	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—liver cancer	7.57e-05	0.000444	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—liver cancer	7.52e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—liver cancer	7.47e-05	0.000438	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—liver cancer	7.46e-05	0.000437	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—liver cancer	7.46e-05	0.000437	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—liver cancer	7.43e-05	0.000436	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—liver cancer	7.41e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—liver cancer	7.38e-05	0.000433	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—liver cancer	7.34e-05	0.00043	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—liver cancer	7.32e-05	0.00043	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—liver cancer	7.31e-05	0.000429	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—liver cancer	7.3e-05	0.000428	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—liver cancer	7.3e-05	0.000428	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—liver cancer	7.28e-05	0.000427	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—liver cancer	7.24e-05	0.000425	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—liver cancer	7.21e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—liver cancer	7.2e-05	0.000422	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—liver cancer	7.2e-05	0.000422	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—liver cancer	7.2e-05	0.000422	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—liver cancer	7.17e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.15e-05	0.000419	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—liver cancer	7.11e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—liver cancer	7.11e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—liver cancer	7.04e-05	0.000413	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—liver cancer	6.97e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—liver cancer	6.96e-05	0.000408	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—liver cancer	6.9e-05	0.000405	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—liver cancer	6.9e-05	0.000405	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—liver cancer	6.85e-05	0.000402	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—liver cancer	6.79e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—liver cancer	6.79e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—liver cancer	6.77e-05	0.000397	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—liver cancer	6.75e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—liver cancer	6.74e-05	0.000395	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—liver cancer	6.73e-05	0.000395	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—liver cancer	6.7e-05	0.000393	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—liver cancer	6.7e-05	0.000393	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—liver cancer	6.67e-05	0.000391	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—liver cancer	6.65e-05	0.00039	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—liver cancer	6.63e-05	0.000389	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—liver cancer	6.58e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—liver cancer	6.56e-05	0.000385	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Epirubicin—liver cancer	6.48e-05	0.00038	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—liver cancer	6.45e-05	0.000378	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—liver cancer	6.44e-05	0.000377	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—liver cancer	6.38e-05	0.000374	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—liver cancer	6.38e-05	0.000374	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.29e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—liver cancer	6.24e-05	0.000366	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—liver cancer	6.19e-05	0.000363	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—liver cancer	6.15e-05	0.000361	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—liver cancer	6.14e-05	0.00036	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—liver cancer	6.13e-05	0.00036	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—liver cancer	6.1e-05	0.000358	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—liver cancer	6.07e-05	0.000356	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—liver cancer	6e-05	0.000352	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—liver cancer	5.96e-05	0.000349	CcSEcCtD
Mycophenolate mofetil—Urticaria—Epirubicin—liver cancer	5.92e-05	0.000347	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—liver cancer	5.9e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—liver cancer	5.9e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—liver cancer	5.89e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—liver cancer	5.89e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—liver cancer	5.69e-05	0.000333	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—liver cancer	5.64e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—liver cancer	5.49e-05	0.000322	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—liver cancer	5.48e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—liver cancer	5.45e-05	0.00032	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—liver cancer	5.45e-05	0.00032	CcSEcCtD
Mycophenolate mofetil—Asthenia—Epirubicin—liver cancer	5.35e-05	0.000314	CcSEcCtD
Mycophenolate mofetil—Pruritus—Epirubicin—liver cancer	5.28e-05	0.000309	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Epirubicin—liver cancer	5.1e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—liver cancer	5.08e-05	0.000298	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—liver cancer	4.95e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Dizziness—Epirubicin—liver cancer	4.93e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—liver cancer	4.88e-05	0.000286	CcSEcCtD
Mycophenolate mofetil—Vomiting—Epirubicin—liver cancer	4.74e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—liver cancer	4.72e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—liver cancer	4.7e-05	0.000276	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—liver cancer	4.7e-05	0.000275	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—liver cancer	4.67e-05	0.000274	CcSEcCtD
Mycophenolate mofetil—Dizziness—Doxorubicin—liver cancer	4.56e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Nausea—Epirubicin—liver cancer	4.43e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—liver cancer	4.39e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—liver cancer	4.35e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—liver cancer	4.35e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—liver cancer	4.32e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Nausea—Doxorubicin—liver cancer	4.1e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTA1—liver cancer	7.93e-06	4.85e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—HMOX1—liver cancer	7.89e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—HMOX1—liver cancer	7.89e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PIK3CA—liver cancer	7.89e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTA1—liver cancer	7.88e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPARA—liver cancer	7.85e-06	4.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NAT2—liver cancer	7.84e-06	4.8e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.81e-06	4.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NAT2—liver cancer	7.8e-06	4.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	7.76e-06	4.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.73e-06	4.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYCS—liver cancer	7.7e-06	4.72e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TAT—liver cancer	7.68e-06	4.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK14—liver cancer	7.6e-06	4.65e-05	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—AKT1—liver cancer	7.58e-06	4.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GGT1—liver cancer	7.56e-06	4.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GOT1—liver cancer	7.56e-06	4.63e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.54e-06	4.61e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALDOB—liver cancer	7.52e-06	4.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	7.51e-06	4.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.5e-06	4.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ALDOB—liver cancer	7.47e-06	4.58e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CG—liver cancer	7.45e-06	4.56e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	7.41e-06	4.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	7.39e-06	4.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—F2—liver cancer	7.37e-06	4.51e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTM1—liver cancer	7.35e-06	4.5e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTM1—liver cancer	7.35e-06	4.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTA4—liver cancer	7.35e-06	4.5e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTP1—liver cancer	7.33e-06	4.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HPGDS—liver cancer	7.24e-06	4.43e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—HMOX1—liver cancer	7.23e-06	4.43e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PPARG—liver cancer	7.19e-06	4.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CRABP1—liver cancer	7.17e-06	4.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTA2—liver cancer	7.16e-06	4.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CRABP1—liver cancer	7.13e-06	4.36e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	7.13e-06	4.36e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CG—liver cancer	7.05e-06	4.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP1A1—liver cancer	6.97e-06	4.27e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP1A1—liver cancer	6.97e-06	4.27e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTA1—liver cancer	6.91e-06	4.23e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	6.9e-06	4.23e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	6.85e-06	4.19e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NAT2—liver cancer	6.83e-06	4.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTP1—liver cancer	6.79e-06	4.16e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTM1—liver cancer	6.74e-06	4.13e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CG—liver cancer	6.72e-06	4.11e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—HMOX1—liver cancer	6.7e-06	4.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALDOB—liver cancer	6.55e-06	4.01e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CD—liver cancer	6.55e-06	4.01e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—MTHFR—liver cancer	6.5e-06	3.98e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—MTHFR—liver cancer	6.5e-06	3.98e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPARG—liver cancer	6.49e-06	3.97e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ALB—liver cancer	6.46e-06	3.96e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.46e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PSMA4—liver cancer	6.45e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PSMD10—liver cancer	6.45e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—liver cancer	6.44e-06	3.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.42e-06	3.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	6.39e-06	3.91e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP1A1—liver cancer	6.39e-06	3.91e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPARA—liver cancer	6.38e-06	3.9e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPARA—liver cancer	6.38e-06	3.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.29e-06	3.85e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GOT2—liver cancer	6.27e-06	3.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HPGDS—liver cancer	6.27e-06	3.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CRABP1—liver cancer	6.25e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	6.25e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTM1—liver cancer	6.24e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HPGDS—liver cancer	6.23e-06	3.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.23e-06	3.81e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CD—liver cancer	6.2e-06	3.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.2e-06	3.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SERPINE1—liver cancer	6.13e-06	3.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.09e-06	3.73e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—MTHFR—liver cancer	5.96e-06	3.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP1A1—liver cancer	5.92e-06	3.62e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CD—liver cancer	5.91e-06	3.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP2E1—liver cancer	5.9e-06	3.61e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPARA—liver cancer	5.84e-06	3.58e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ALB—liver cancer	5.83e-06	3.57e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—liver cancer	5.75e-06	3.52e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.73e-06	3.51e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CB—liver cancer	5.71e-06	3.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.68e-06	3.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.64e-06	3.45e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.6e-06	3.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PSMD10—liver cancer	5.59e-06	3.42e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PSMA4—liver cancer	5.59e-06	3.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PSMD10—liver cancer	5.56e-06	3.4e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PSMA4—liver cancer	5.56e-06	3.4e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—RAF1—liver cancer	5.53e-06	3.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYCS—liver cancer	5.52e-06	3.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—MTHFR—liver cancer	5.51e-06	3.38e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CG—liver cancer	5.46e-06	3.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HPGDS—liver cancer	5.46e-06	3.34e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CG—liver cancer	5.46e-06	3.34e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GOT2—liver cancer	5.43e-06	3.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GOT1—liver cancer	5.42e-06	3.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GGT1—liver cancer	5.42e-06	3.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPARA—liver cancer	5.41e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GOT2—liver cancer	5.4e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CB—liver cancer	5.4e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPARG—liver cancer	5.27e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPARG—liver cancer	5.27e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.25e-06	3.21e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CPT1B—liver cancer	5.22e-06	3.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GLUL—liver cancer	5.22e-06	3.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	5.22e-06	3.2e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CB—liver cancer	5.15e-06	3.15e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.14e-06	3.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP2E1—liver cancer	5.11e-06	3.13e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP2E1—liver cancer	5.08e-06	3.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NR1H4—liver cancer	5.03e-06	3.08e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CG—liver cancer	5e-06	3.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—liver cancer	4.96e-06	3.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA3—liver cancer	4.95e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.95e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.92e-06	3.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PSMA4—liver cancer	4.87e-06	2.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PSMD10—liver cancer	4.87e-06	2.98e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—liver cancer	4.87e-06	2.98e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPARG—liver cancer	4.83e-06	2.96e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CD—liver cancer	4.8e-06	2.94e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CD—liver cancer	4.8e-06	2.94e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HMOX1—liver cancer	4.8e-06	2.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	4.79e-06	2.93e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYCS—liver cancer	4.78e-06	2.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYCS—liver cancer	4.75e-06	2.91e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ALB—liver cancer	4.74e-06	2.9e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ALB—liver cancer	4.74e-06	2.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GOT2—liver cancer	4.73e-06	2.9e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—liver cancer	4.7e-06	2.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GOT1—liver cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GGT1—liver cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GOT1—liver cancer	4.66e-06	2.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GGT1—liver cancer	4.66e-06	2.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.64e-06	2.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CG—liver cancer	4.63e-06	2.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA4—liver cancer	4.53e-06	2.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPARG—liver cancer	4.47e-06	2.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTM1—liver cancer	4.47e-06	2.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2E1—liver cancer	4.45e-06	2.72e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA2—liver cancer	4.41e-06	2.7e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CD—liver cancer	4.4e-06	2.69e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ALB—liver cancer	4.34e-06	2.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA1—liver cancer	4.26e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1A1—liver cancer	4.24e-06	2.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—liver cancer	4.22e-06	2.58e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—liver cancer	4.21e-06	2.58e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NAT2—liver cancer	4.21e-06	2.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—liver cancer	4.19e-06	2.56e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CB—liver cancer	4.18e-06	2.56e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CB—liver cancer	4.18e-06	2.56e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYCS—liver cancer	4.17e-06	2.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HMOX1—liver cancer	4.16e-06	2.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HMOX1—liver cancer	4.13e-06	2.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GOT1—liver cancer	4.09e-06	2.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GGT1—liver cancer	4.09e-06	2.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CD—liver cancer	4.07e-06	2.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALDOB—liver cancer	4.03e-06	2.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALB—liver cancer	4.02e-06	2.46e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—MTHFR—liver cancer	3.95e-06	2.42e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPARA—liver cancer	3.88e-06	2.37e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTM1—liver cancer	3.87e-06	2.37e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB1—liver cancer	3.87e-06	2.37e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTM1—liver cancer	3.85e-06	2.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CRABP1—liver cancer	3.85e-06	2.36e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CB—liver cancer	3.83e-06	2.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—liver cancer	3.67e-06	2.25e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1A1—liver cancer	3.67e-06	2.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1A1—liver cancer	3.65e-06	2.23e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HMOX1—liver cancer	3.62e-06	2.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—liver cancer	3.59e-06	2.19e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CB—liver cancer	3.55e-06	2.17e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—liver cancer	3.48e-06	2.13e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—MTHFR—liver cancer	3.42e-06	2.09e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—MTHFR—liver cancer	3.4e-06	2.08e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTM1—liver cancer	3.37e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HPGDS—liver cancer	3.36e-06	2.06e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPARA—liver cancer	3.36e-06	2.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPARA—liver cancer	3.34e-06	2.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CG—liver cancer	3.32e-06	2.03e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—liver cancer	3.29e-06	2.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPARG—liver cancer	3.2e-06	1.96e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1A1—liver cancer	3.2e-06	1.96e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—liver cancer	3.19e-06	1.95e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—liver cancer	3.14e-06	1.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—liver cancer	3.05e-06	1.87e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.02e-06	1.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PSMA4—liver cancer	3e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PSMD10—liver cancer	3e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—MTHFR—liver cancer	2.98e-06	1.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPARA—liver cancer	2.93e-06	1.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CD—liver cancer	2.92e-06	1.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GOT2—liver cancer	2.92e-06	1.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALB—liver cancer	2.88e-06	1.76e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CG—liver cancer	2.88e-06	1.76e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CG—liver cancer	2.86e-06	1.75e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—liver cancer	2.84e-06	1.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPARG—liver cancer	2.78e-06	1.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPARG—liver cancer	2.76e-06	1.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2E1—liver cancer	2.74e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—liver cancer	2.69e-06	1.65e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYCS—liver cancer	2.57e-06	1.57e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—liver cancer	2.56e-06	1.57e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—liver cancer	2.55e-06	1.56e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—liver cancer	2.55e-06	1.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CB—liver cancer	2.54e-06	1.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CD—liver cancer	2.53e-06	1.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GOT1—liver cancer	2.52e-06	1.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GGT1—liver cancer	2.52e-06	1.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CD—liver cancer	2.51e-06	1.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CG—liver cancer	2.51e-06	1.53e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALB—liver cancer	2.5e-06	1.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPARG—liver cancer	2.42e-06	1.48e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—liver cancer	2.34e-06	1.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—liver cancer	2.26e-06	1.38e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HMOX1—liver cancer	2.23e-06	1.37e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CB—liver cancer	2.2e-06	1.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CD—liver cancer	2.2e-06	1.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CB—liver cancer	2.19e-06	1.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALB—liver cancer	2.17e-06	1.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—liver cancer	2.16e-06	1.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—liver cancer	2.08e-06	1.28e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—liver cancer	2.08e-06	1.28e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTM1—liver cancer	2.08e-06	1.27e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1A1—liver cancer	1.97e-06	1.21e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CB—liver cancer	1.92e-06	1.17e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—liver cancer	1.91e-06	1.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTHFR—liver cancer	1.84e-06	1.12e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPARA—liver cancer	1.8e-06	1.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—liver cancer	1.77e-06	1.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—liver cancer	1.55e-06	9.49e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CG—liver cancer	1.54e-06	9.45e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPARG—liver cancer	1.49e-06	9.12e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CD—liver cancer	1.36e-06	8.3e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—liver cancer	1.34e-06	8.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALB—liver cancer	1.34e-06	8.2e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—liver cancer	1.34e-06	8.17e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—liver cancer	1.27e-06	7.75e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CB—liver cancer	1.18e-06	7.24e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—liver cancer	1.17e-06	7.16e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—liver cancer	1.1e-06	6.72e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—liver cancer	1.09e-06	6.68e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—liver cancer	9.56e-07	5.85e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—liver cancer	7.21e-07	4.41e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—liver cancer	5.89e-07	3.6e-06	CbGpPWpGaD
